0,958  0,002  Cardiovascular analeptic
0,900  0,004  Respiratory analeptic
0,880  0,003  Analeptic
0,829  0,004  Urologic disorders treatment
0,825  0,004  Psychostimulant
0,804  0,003  Cardiodepressant
0,786  0,004  Spasmolytic
0,770  0,004  Urinary incontinence treatment
0,742  0,015  CYP3A4 substrate
0,732  0,005  5 Hydroxytryptamine release stimulant
0,727  0,009  Antiobesity
0,728  0,014  Teratogen
0,714  0,014  Embryotoxic
0,702  0,006  Vasodilator, peripheral
0,676  0,008  CYP2D6 substrate
0,660  0,004  FMO1 substrate
0,686  0,033  Apoptosis agonist
0,627  0,012  CYP1A2 substrate
0,628  0,013  Sensitization
0,613  0,005  Calcium channel L-type activator
0,600  0,004  Antihypotensive
0,599  0,010  Histamine release inhibitor
0,582  0,007  Vasodilator
0,576  0,005  Flavin-containing monooxygenase substrate
0,588  0,018  Carcinogenic
0,574  0,004  Bronchodilator
0,569  0,005  Muscle relaxant
0,562  0,010  Cardiotonic
0,579  0,029  TNF expression inhibitor
0,561  0,018  CYP2C19 substrate
0,549  0,010  CYP2D6 inhibitor
0,534  0,003  Peptidyltransferase inhibitor
0,527  0,012  Eye irritation, high
0,524  0,013  Vasodilator, coronary
0,504  0,028  Antithrombotic
0,491  0,024  Radioprotector
0,500  0,041  GST A substrate
0,494  0,034  5 Hydroxytryptamine release inhibitor
0,454  0,007  Alpha-N-acetylglucosaminidase inhibitor
0,483  0,036  Antiasthmatic
0,449  0,004  Antieczematic
0,450  0,010  Antianorexic
0,480  0,040  CYP2C9 substrate
0,496  0,061  Caspase 9 stimulant
0,468  0,039  Toll-Like receptor 7 agonist
0,467  0,039  Toll-Like receptor agonist
0,433  0,005  Antitussive
0,464  0,038  Aldehyde oxidase inhibitor
0,432  0,007  Antiadrenergic
0,428  0,007  Adrenaline antagonist
0,456  0,037  CYP2C19 inhibitor
0,429  0,013  Antiarrhythmic
0,423  0,008  Urolithiasis treatment
0,419  0,005  CNS active muscle relaxant
0,425  0,018  UDP-glucuronosyltransferase substrate
0,406  0,006  Anesthetic local
0,406  0,018  Interleukin agonist
0,401  0,015  Antiparkinsonian, rigidity relieving
0,395  0,015  5 Hydroxytryptamine uptake stimulant
0,405  0,026  Chronic obstructive pulmonary disease treatment
0,439  0,061  Antibacterial
0,400  0,031  UGT2B4 substrate
0,370  0,009  Antiparkinsonian, tremor relieving
0,363  0,004  Carcinogenic, group 2A
0,379  0,025  FMO3 substrate
0,374  0,024  Peroxidase inhibitor
0,351  0,006  SULT1A3 substrate
0,347  0,003  Adrenaline agonist
0,424  0,080  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,365  0,034  Mutagenic
0,343  0,016  Anesthetic
0,339  0,013  Muscular dystrophy treatment
0,339  0,014  Acaricide
0,355  0,032  Antineoplastic (small cell lung cancer)
0,372  0,050  Antihypertensive
0,321  0,008  Aldehyde oxidase substrate
0,319  0,009  Psychosexual dysfunction treatment
0,351  0,042  Antineoplastic (multiple myeloma)
0,324  0,018  Skeletal muscle relaxant
0,353  0,048  Calcium channel activator
0,312  0,006  Antispirochetal
0,309  0,005  Alpha adrenoreceptor agonist
0,303  0,004  Phenylalanine 4-hydroxylase inhibitor
0,301  0,003  Antirickettsial
0,347  0,051  CTGF expression inhibitor
0,367  0,072  Transcription factor NF kappa B inhibitor
0,323  0,030  Abortion inducer
0,289  0,004  Sphingomyelinase inhibitor
0,296  0,012  Antihyperlipoproteinemic
0,339  0,057  CYP3A4 inhibitor
0,344  0,067  Cholesterol antagonist
0,379  0,103  Antidiabetic
0,379  0,103  Cyclophilin D inhibitor
0,325  0,050  Chemoprotective
0,285  0,013  UGT2B9 substrate
0,323  0,053  UGT1A9 substrate
0,285  0,017  Acetylcholine M1 receptor antagonist
0,269  0,003  Restless leg syndrome treatment
0,299  0,034  Tyrosine 3 hydroxylase inhibitor
0,277  0,016  Antiviral (West Nile virus)
0,273  0,017  Adenylate cyclase inhibitor
0,302  0,048  Antiglaucomic
0,263  0,011  Ferrochelatase inhibitor
0,342  0,095  Antipruritic, allergic
0,260  0,016  Rhinitis treatment
0,280  0,038  Anesthetic general
0,308  0,068  Interleukin 2 agonist
0,318  0,079  ICAM1 expression inhibitor
0,241  0,002  Baculoviral IAP repeat-containing protein inhibitor
0,257  0,019  Antidiarrheal
0,249  0,013  UGT2B10 substrate
0,261  0,026  Nitric-oxide synthase stimulant
0,252  0,017  Carcinogenic, group 1
0,308  0,076  Immunostimulant
0,265  0,036  UGT2B7 substrate
0,296  0,068  Hypoxia-inducible factor 1 alpha inhibitor
0,303  0,076  Sodium/bile acid cotransporter inhibitor
0,242  0,018  Cell wall synthesis inhibitor
0,323  0,100  Calpain 2 inhibitor
0,301  0,078  Caspase 3 stimulant
0,274  0,054  Gastrin inhibitor
0,224  0,004  NMDA 2A receptor antagonist
0,297  0,080  Antineoplastic (endocrine cancer)
0,223  0,006  Adenylate cyclase stimulant
0,229  0,013  SULT1A1 substrate
0,266  0,055  UGT1A6 substrate
0,215  0,004  Beta adrenoreceptor antagonist
0,277  0,066  Radiosensitizer
0,212  0,004  Beta 3 adrenoreceptor antagonist
0,208  0,004  Alpha 2 adrenoreceptor agonist
0,289  0,086  Antifungal
0,215  0,012  Growth stimulant
0,277  0,076  Antihypoxic
0,217  0,017  Excitatory amino acid transporter EAAC1 inhibitor
0,231  0,032  Antiseptic
0,308  0,110  CYP2C9 inhibitor
0,205  0,008  Myasthenia Gravis treatment
0,207  0,011  Gastritis treatment
0,202  0,006  Tocolytic
0,227  0,033  UGT2B15 substrate
0,300  0,107  Ulceration
0,262  0,068  NOS2 expression inhibitor
0,195  0,004  Uterine relaxant
0,266  0,078  GST M1-1 substrate
0,222  0,035  5 Hydroxytryptamine 3E antagonist
0,214  0,028  Cholinergic antagonist
0,232  0,047  CYP2B6 inhibitor
0,235  0,053  UGT1A1 substrate
0,215  0,037  VEGF expression inhibitor
0,201  0,024  Acetylcholine muscarinic antagonist
0,241  0,065  Neuropeptide Y2 antagonist
0,240  0,064  Cytotoxic
0,205  0,029  Acetylcholine antagonist
0,259  0,088  Insulysin inhibitor
0,223  0,053  Insulin sensitizer
0,220  0,050  UGT1A4 substrate
0,203  0,034  Genotoxic
0,228  0,059  Sedative
0,242  0,073  Calpain inhibitor
0,173  0,004  Beta 2 adrenoreceptor antagonist
0,173  0,004  Beta 1 adrenoreceptor antagonist
0,176  0,012  NMDA 2 receptor antagonist
0,238  0,076  DNA synthesis inhibitor
0,171  0,010  Toll-Like receptor 3 antagonist
0,171  0,013  Glutamate dehydrogenase inhibitor
0,176  0,020  Mucolytic
0,163  0,009  Antihypermotility
0,173  0,021  Sulfotransferase substrate
0,191  0,040  Tubulin antagonist
0,236  0,085  Hypoglycemic
0,158  0,009  Adrenaline uptake inhibitor
0,186  0,037  Raynaud's phenomenon treatment
0,167  0,020  NMDA receptor antagonist
0,170  0,027  Coagulant
0,172  0,029  Antiviral (Poxvirus)
0,164  0,023  Catalase inhibitor
0,222  0,081  Cytostatic
0,290  0,149  Analgesic
0,169  0,028  Expectorant
0,229  0,089  Antihypercholesterolemic
0,163  0,024  UGT2B1 substrate
0,170  0,034  Glutathione S-transferase substrate
0,204  0,070  Pneumotoxic
0,203  0,069  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,155  0,021  Arylamine N-Acetyltransferase substrate
0,270  0,137  GABA C receptor rho-3 antagonist
0,137  0,005  Antiviral (Parainfluenza)
0,141  0,011  Dopamine uptake inhibitor
0,157  0,028  Ca2+-transporting ATPase inhibitor
0,170  0,041  Skin irritative effect
0,171  0,042  Cocaine dependence treatment
0,209  0,081  Antiparasitic
0,131  0,003  Beta adrenoreceptor agonist
0,145  0,017  Transcription factor NF kappa B stimulant
0,160  0,033  Microtubule formation inhibitor
0,160  0,033  Aminopeptidase B inhibitor
0,130  0,003  Beta 2 adrenoreceptor agonist
0,141  0,015  Glutamate decarboxylase inhibitor
0,153  0,028  Antineoplastic, alkylator
0,178  0,054  Uterine stimulant
0,200  0,077  Neurotrophic factor enhancer
0,143  0,020  GST T1-1 substrate
0,140  0,017  5 Hydroxytryptamine uptake inhibitor
0,141  0,019  UGT2B11 substrate
0,148  0,026  Chronic obstructive bronchitis treatment
0,157  0,036  Antineoplastic antimetabolite
0,176  0,055  Neurotensin receptor agonist
0,177  0,056  Diuretic
0,167  0,046  Neurotrophic factor
0,193  0,073  Antiviral (Ebola)
0,215  0,095  Heart failure treatment
0,137  0,018  Glutamate (mGluR7) agonist
0,200  0,081  Pyruvate kinase inhibitor
0,136  0,018  Somatostatin 1 agonist
0,166  0,048  Carcinogenic, group 3
0,131  0,013  Carbonic anhydrase stimulant
0,136  0,019  Antidote, mercury
0,235  0,118  12-Lipoxygenase inhibitor
0,122  0,005  Gaucher disease treatment
0,170  0,054  Corneal wound healing stimulator
0,139  0,024  Potassium channel activator
0,119  0,004  Diamine oxidase inhibitor
0,139  0,027  GABA C receptor rho-1 antagonist
0,230  0,118  Antidepressant
0,200  0,088  VCAM1 expression inhibitor
0,166  0,055  GABA C receptor rho-2 antagonist
0,130  0,019  Ornithine decarboxylase inhibitor
0,219  0,109  5 Hydroxytryptamine 1E antagonist
0,169  0,058  Hair growth stimulant
0,146  0,036  Shock treatment
0,135  0,027  Anabolic
0,120  0,013  NMDA receptor agonist
0,142  0,035  GABA C receptor antagonist
0,130  0,025  Paget's disease treatment
0,124  0,020  Glutamate release inhibitor
0,172  0,068  UGT1A3 substrate
0,192  0,089  Antimitotic
0,113  0,010  Endocannabinoid uptake inhibitor
0,151  0,049  Antiprotozoal (Trichomonas)
0,134  0,032  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,121  0,019  Aminopeptidase I inhibitor
0,258  0,156  Atherosclerosis treatment
0,116  0,015  Acetylcholine M3 receptor antagonist
0,135  0,033  Adenylate kinase inhibitor
0,110  0,009  Antidote, organophosphates
0,133  0,032  Electron transport complex I inhibitor
0,209  0,108  Superoxide dismutase inhibitor
0,211  0,112  Proliferative diseases treatment
0,122  0,026  Xanthine oxidase substrate
0,156  0,059  Movement disorders treatment
0,143  0,052  Antismoking
0,119  0,029  Antiviral (Rhinovirus)
0,105  0,016  Acetylcholine M5 receptor antagonist
0,125  0,037  Creatine kinase inhibitor
0,159  0,071  Antimutagenic
0,111  0,023  Nicotinic alpha4beta2 receptor antagonist
0,170  0,083  Antipruritic, non-allergic
0,169  0,082  Succinate dehydrogenase inhibitor
0,123  0,036  Nitric-oxide synthase inhibitor
0,242  0,155  Immunosuppressant
0,267  0,181  Antiarthritic
0,126  0,040  Urease inhibitor
0,188  0,103  Cyclic AMP phosphodiesterase inhibitor
0,108  0,023  Antiviral (Hepatitis A)
0,113  0,029  Antibiotic
0,139  0,055  Cathepsin H inhibitor
0,140  0,057  Cyclooxygenase 3 inhibitor
0,112  0,030  Gastroesophageal reflux disease treatment
0,098  0,016  Phospholipase D inhibitor
0,165  0,084  Phobic disorders treatment
0,128  0,047  Transcription factor STAT6 inhibitor
0,162  0,082  ATPase inhibitor
0,125  0,046  GABA C receptor agonist
0,138  0,060  Retinoprotector
0,113  0,037  Triose-phosphate isomerase inhibitor
0,124  0,049  Protein kinase C gamma inhibitor
0,130  0,055  Contraceptive female
0,109  0,035  NADH dehydrogenase inhibitor
0,142  0,070  Antineoplastic (squamous cell carcinoma)
0,112  0,041  Posttraumatic stress disorder treatment
0,082  0,010  Alpha-mannosidase inhibitor
0,161  0,090  Toxic, respiratory center
0,120  0,049  Alpha 2c adrenoreceptor antagonist
0,087  0,017  SULT2A1 substrate
0,111  0,041  Lanosterol 14 alpha demethylase inhibitor
0,097  0,027  Narcotic antagonist
0,088  0,019  Caspase 9 inhibitor
0,119  0,050  HDL-cholesterol increasing
0,123  0,054  Photosensitizer
0,173  0,105  Anticonvulsant
0,175  0,107  Antiulcerative
0,143  0,075  Thiol protease inhibitor
0,120  0,052  Nav1.4 sodium channel blocker
0,092  0,025  Female sexual dysfunction treatment
0,102  0,035  Inducible nitric-oxide synthase inhibitor
0,091  0,025  Vanilloid 4 agonist
0,149  0,083  Melanin inhibitor
0,127  0,060  Proteasome inhibitor
0,108  0,043  Calcium antagonist
0,095  0,031  Estrogen-related receptor beta agonist
0,205  0,141  Antipsoriatic
0,113  0,049  UDP-glucose 4-epimerase inhibitor
0,112  0,048  GST P1-1 substrate
0,139  0,076  Pregnane X receptor agonist
0,099  0,037  Granulocyte macrophage colony stimulating factor agonist
0,078  0,016  Antibiotic Glycopeptide-like
0,127  0,066  Papain-like protease (SARS coronavirus) inhibitor
0,112  0,050  Carbonic anhydrase III inhibitor
0,064  0,004  Ceramide glucosyltransferase inhibitor
0,071  0,011  Mannosidase inhibitor
0,119  0,059  Alpha 2b adrenoreceptor antagonist
0,137  0,078  Protein kinase stimulant
0,104  0,045  Alpha 2 adrenoreceptor antagonist
0,060  0,002  Baculoviral IAP repeat-containing protein 3 inhibitor
0,069  0,012  Immunoglobulin Fc receptor antagonist
0,096  0,039  Histamine H2 receptor antagonist
0,134  0,078  Attention deficit/hyperactivity disorder treatment
0,057  0,004  Beta 1 adrenoreceptor agonist
0,099  0,046  Aminoacyl-tRNA synthetase inhibitor
0,126  0,073  Vanilloid 1 agonist
0,079  0,026  Argininosuccinate synthase inhibitor
0,126  0,073  Antibacterial (Helicobacter pylori)
0,068  0,016  Lysophosphatidic acid 3 receptor antagonist
0,120  0,068  Alkylator
0,077  0,025  Antimycoplasmal
0,072  0,020  Sphingosine kinase 2 inhibitor
0,061  0,010  Membrane dipeptidase inhibitor
0,111  0,060  Falcipain 3 inhibitor
0,091  0,041  Alpha 2a adrenoreceptor antagonist
0,141  0,091  Interferon gamma antagonist
0,077  0,028  Glutamate (mGluR6) antagonist
0,111  0,061  Choleretic
0,067  0,019  Potassium channel (Inward rectifier) blocker
0,059  0,011  Alpha 1d adrenoreceptor agonist
0,070  0,022  Glucosylceramidase inhibitor
0,055  0,008  Sodium-dependent vitamin C transporter 2 inhibitor
0,063  0,016  NMDA receptor subunit 3A antagonist
0,183  0,137  Antineoplastic (ovarian cancer)
0,076  0,031  5 Hydroxytryptamine 2A agonist
0,049  0,004  Ileal bile acid transport inhibitor
0,108  0,062  Carcinogenic, group 2B
0,150  0,106  Phospholipase C inhibitor
0,075  0,031  Carbamoyl phosphate synthetase inhibitor
0,070  0,027  Acyl-CoA dehydrogenase inhibitor
0,069  0,026  Sphingosine kinase inhibitor
0,065  0,022  Sphingosine 1-phosphate receptor 1 antagonist
0,083  0,041  Sphingosine 1-phosphate receptor antagonist
0,118  0,076  Nav1.3 sodium channel blocker
0,081  0,040  GABA B receptor agonist
0,054  0,013  Glucocorticoid antagonist
0,044  0,004  Beta 3 adrenoreceptor agonist
0,082  0,042  NAT1 substrate
0,071  0,032  NMDA 2C receptor antagonist
0,112  0,073  Cholesterol synthesis inhibitor
0,132  0,093  Antifungal (Cryptococcus)
0,041  0,002  Baculoviral IAP repeat-containing protein 2 inhibitor
0,131  0,092  Antidote
0,086  0,049  Acetylcholine nicotinic antagonist
0,072  0,035  Antihemophilic
0,062  0,025  5 Hydroxytryptamine 2 agonist
0,096  0,059  Prolactin inhibitor
0,138  0,102  Arachidonic acid antagonist
0,176  0,140  RNA-directed DNA polymerase inhibitor
0,101  0,065  Carbonic anhydrase XV inhibitor
0,049  0,013  Vesicle monoamine transporter inhibitor
0,161  0,126  Hypolipemic
0,126  0,092  Aurora-C kinase inhibitor
0,148  0,114  Septic shock treatment
0,063  0,029  Ornithine carbamoyltransferase inhibitor
0,038  0,004  Acid ceramidase inhibitor
0,066  0,033  Cathepsin E inhibitor
0,043  0,010  Tryptophan 5 hydroxylase inhibitor
0,194  0,161  Mood disorders treatment
0,038  0,006  Lysophosphatidic acid receptor 1 agonist
0,059  0,027  Factor IXa inhibitor
0,066  0,035  Purinergic P2X1 antagonist
0,073  0,042  Sphingosine 1-phosphate receptor 4 agonist
0,038  0,008  Purinergic P2Y15 antagonist
0,092  0,063  HIV-1 integrase (Overall Integration) inhibitor
0,048  0,019  Sphingosine kinase 1 inhibitor
0,047  0,018  Kainate receptor agonist
0,041  0,012  Lysophosphatidic acid 2 receptor antagonist
0,118  0,090  Calcium channel blocker
0,075  0,048  Cathepsin G inhibitor
0,062  0,035  Alpha 1 adrenoreceptor agonist
0,083  0,057  Antiprotozoal activity enhancer
0,133  0,107  Antihelmintic (Nematodes)
0,049  0,023  Histamine H2 receptor agonist
0,104  0,078  Acetylcholine release stimulant
0,117  0,092  Antifungal enhancer
0,050  0,025  NMDA receptor subunit 3B antagonist
0,057  0,032  Neuropeptide Y5 antagonist
0,062  0,038  Aminopeptidase microsomal inhibitor
0,045  0,020  Oxytocin antagonist
0,092  0,068  Interleukin 1 beta converting enzyme inhibitor
0,057  0,033  Protein 50S ribosomal subunit inhibitor
0,078  0,055  Interferon agonist
0,056  0,032  Nicotinic alpha3beta2 receptor antagonist
0,066  0,043  CDC25B inhibitor
0,077  0,054  MAP kinase kinase 7 inhibitor
0,049  0,026  Neuraminidase (Influenza A) inhibitor
0,028  0,005  Neuraminidase (Influenza B) inhibitor
0,111  0,089  Antiviral (Influenza B)
0,115  0,093  Antihelmintic (Trematoda)
0,083  0,062  mTOR complex 2 inhibitor
0,065  0,044  Neuraminidase (influenza) inhibitor
0,042  0,022  Cholesterol absorption inhibitor
0,032  0,012  Baculoviral IAP repeat-containing protein 4 inhibitor
0,043  0,024  Somatostatin 1 antagonist
0,025  0,006  Alpha 2a adrenoreceptor agonist
0,064  0,045  Interferon inducer
0,056  0,037  Protein kinase C eta inhibitor
0,031  0,013  1,3-Beta-glucan synthase inhibitor
0,059  0,041  Beta tubulin antagonist
0,035  0,017  Endothelial nitric-oxide synthase inhibitor
0,188  0,171  AR expression inhibitor
0,100  0,084  5 Hydroxytryptamine 2B antagonist
0,073  0,057  Na+ K+ transporting ATPase inhibitor
0,028  0,012  Alpha 1a adrenoreceptor agonist
0,118  0,102  Sphingosine 1-phosphate receptor 2 antagonist
0,024  0,008  Apical sodium codependent bile acid transporter inhibitor
0,049  0,034  Antiviral (Herpesvirus 3, Human)
0,066  0,051  Phosphofructokinase-1 inhibitor
0,027  0,013  Vanilloid 2 agonist
0,051  0,037  Aconitate hydratase inhibitor
0,044  0,030  Histamine H1 receptor agonist
0,058  0,045  Neuraminidase inhibitor
0,018  0,006  Lysophosphatidic acid receptor 3 agonist
0,050  0,037  Anesthetic inhalation
0,061  0,048  Hyperparathyroidism treatment
0,047  0,035  Dopamine transporter inhibitor
0,090  0,078  NAT2 substrate
0,070  0,059  Adenosine A3 receptor antagonist
0,094  0,084  Factor V inhibitor
0,014  0,005  Immunosuppressant Cyclosporine-like
0,055  0,046  Biliverdin reductase inhibitor
0,039  0,030  Toll-Like receptor 2 agonist
0,087  0,078  Protease inhibitor
0,092  0,083  Folate antagonist
0,052  0,043  Alcohol oxidase inhibitor
0,020  0,012  Antibiotic Anthracycline-like
0,064  0,057  Histidine decarboxylase inhibitor
0,028  0,020  Estrogen-related receptor gamma antagonist
0,047  0,039  Cytokine production stimulant
0,040  0,033  3-Hydroxyanthranilate 3,4-dioxygenase inhibitor
0,021  0,014  Lysophosphatidic acid 1 receptor antagonist
0,037  0,031  5 Hydroxytryptamine 2B agonist
0,082  0,075  Antihistaminic
0,080  0,073  Interleukin 5 antagonist
0,031  0,025  Calcitonin receptor agonist
0,031  0,025  Glutamate (mGluR3) agonist
0,063  0,057  Glutamate (mGluR7) antagonist
0,052  0,047  Kallikrein 1 inhibitor
0,081  0,076  Actinic keratosis treatment
0,030  0,026  GABA transporter 3 inhibitor
0,174  0,170  Antiischemic
0,017  0,013  Aminopeptidase A inhibitor
0,025  0,020  CXC chemokine 2 receptor antagonist
0,181  0,177  NOS3 expression inhibitor
0,036  0,032  Vascular adhesion protein 1 inhibitor
0,086  0,084  Gastric antisecretory
0,053  0,051  Androgen agonist
0,087  0,085  Nav1.1 sodium channel blocker
0,029  0,027  Methionyl aminopeptidase 1 inhibitor
0,058  0,056  Neuronal nicotinic receptor antagonist
0,073  0,071  Neuropeptide Y antagonist
0,039  0,038  Geranyltranstransferase inhibitor
0,098  0,097  Menstruation disorders treatment
0,049  0,047  Leukotriene B4 antagonist
0,039  0,038  Phosphorylase inhibitor
0,035  0,034  Glutamate (mGluR8) agonist
0,045  0,044  Ribonucleoside-diphosphate reductase inhibitor
0,018  0,017  Caspase 8 inhibitor
0,046  0,045  Ribonucleotide reductase inhibitor
0,063  0,062  Protein kinase C beta inhibitor
0,058  0,057  Protease 3C (Human rhinovirus) inhibitor
0,017  0,017  Alpha 2c adrenoreceptor agonist
0,036  0,036  Oxytocin agonist

